Safety
EC-HC-II and HC-II were considered safe and tolerable, and no clinically significant abnormalities or changes related to EC-HC-II and HC-II were identified. The results of laboratory tests, including alanine aminotransferase, aspartate aminotransferase, total bilirubin, albumin, and total protein tests, remained normal and stable across 24 weeks.